Archive

Talk at The Pharma Imaging Network for Therapeutics and Diagnostics (PINTaD) – Advancing Oncology Imaging Beyond RECIST 1.1

Read More

ASCO 2025, posters and abstracts continue validation of Onc.AI models​

Read More

GSK validation of Serial CTRS at AACR 2025

Read More

FDA Breakthrough Device Designation

Read More

Onc.AI Serial Imaging Response Score Outperforms Traditional Methods for Early Assessment of NSCLC Immunotherapy Outcomes

Read More

$2mm National Cancer Institute SBIR Grant

Read More

Radiomics: The Intersection of Modern Deep Learning and Clinical Imaging

Read More

Onc.AI To Present Collaboration Results at ASCO 2024

Read More

$25mm Series A Financing

Read More

$6mm Series Seed Financing

Read More